Cintas delivered strong operational growth with 15.3% net income increase and expanded share buybacks, but increased debt load and higher interest expense warrant monitoring.
The company demonstrates healthy business expansion with revenue growing to $10.3B, operating leverage driving margin improvement, and aggressive capital returns through $935M in share buybacks. However, the 19.7% debt increase and 25.2% jump in interest expense suggest management is using leverage to fund growth and returns, which increases financial risk in a higher rate environment.
Cintas shows strong operational performance with net income growing 15.3% to $1.8B and gross profit expanding 10.4% to $5.2B, demonstrating effective cost management and pricing power. The company significantly increased share buybacks by 33.5% to $935M while expanding operations (400 more delivery routes, 11 more facilities), but funded this through higher debt levels that increased total debt 19.7% to $2.4B. The combination of reduced cash position, higher interest expense (+25.2%), and increased leverage creates a more aggressive capital structure that amplifies both returns and financial risk.
Share repurchases increased 33.5% — management returning capital, signals confidence in intrinsic value.
Interest costs rose 25.2% — monitor debt levels and coverage ratio in rising rate environment.
Cash decreased 22.8% — monitor burn rate and upcoming capital needs.
Debt rose 19.7% — additional borrowing for investment or operations; monitor coverage ratios.
Net income grew 15.3% — bottom-line growth signals improving overall business health.
Operating income improving — cost discipline or growing revenue base absorbing fixed costs.
Receivables grew 13.9% — monitor days sales outstanding for collection efficiency.
Revenue softened 10.6% — monitor whether this is cyclical or structural.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Current liabilities reduced — improved short-term financial position and working capital health.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →